Immobilized heavy chain-hyaluronic acid polarizes lipopolysaccharide- activated macrophages toward m2 phenotype

Journal of Biological Chemistry

Volumn 288, Issue 36, 2013, Pages 25792-25803

  He, Hua ^a   Zhang, Suzhen ^a   Tighe, Sean ^a   Son, Ji ^b   Tseng, Scheffer C G ^a,b,c  

^a TISSUETECH INC   (United States)

^b Ocular Surface Research Education Foundation   (United States)

^c OCULAR SURFACE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED MACROPHAGES; ANTI-INFLAMMATORIES; ANTI-INFLAMMATORY ACTION; LIPOPOLYSACCHARIDES; MATRIX COMPONENTS;

ANTIGEN-ANTIBODY REACTIONS; CELL DEATH; MACROPHAGES; ORGANIC ACIDS;

HYALURONIC ACID;

FORMYLMETHIONYLLEUCYLPHENYLALANINE; HERPESVIRUS ENTRY MEDIATOR LIGAND; HYALURONIC ACID; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERFERON REGULATORY FACTOR 5; INTERLEUKIN 10; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; PENTRAXIN 3; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SPHINGOSINE KINASE 1; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

AMNION; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; BINDING KINETICS; CELL ADHESION; CELL NUCLEUS; CELL PROLIFERATION; CELL SPREADING; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; INHIBITION KINETICS; LEUKOCYTE ACTIVATION; MACROPHAGE ACTIVATION; PHAGOCYTOSIS; PHENOTYPE; POLARIZATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; UPREGULATION; WOUND HEALING;

AMNIOTIC MEMBRANE, HC-HA, M1/M2 PHENOTYPE; APOPTOSIS; CELL ADHESION; CELL PROLIFERATION; INFLAMMATION; MACROPHAGES; PHAGOCYTOSIS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CELL LINE; CYTOKINES; DOWN-REGULATION; HUMANS; HYALURONIC ACID; INTERFERON REGULATORY FACTORS; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; NEUTROPHILS; NITRIC OXIDE SYNTHASE TYPE II; PHAGOCYTOSIS; PPAR GAMMA; TOLL-LIKE RECEPTORS;

EID: 84883727323     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.479584     Document Type: Article

References (90)

1. Frasch, S. C., Nick, J. A., Fadok, V. A., Bratton, D. L., Worthen, G. S., and Henson, P. M. (1998) p38 mitogen-activated protein kinase-dependent and-independent intracellular signal transduction pathways leading to apoptosis in human neutrophils. J. Biol. Chem. 273, 8389-8397
2. Pongracz, J., Webb, P., Wang, K., Deacon, E., Lunn, O. J., and Lord, J. M. (1999) Spontaneous neutrophil apoptosis involves caspase 3-mediated activation of protein kinase C-delta. J. Biol. Chem. 274, 37329-37334
3. Khwaja, A., and Tatton, L. (1999) Caspase-mediated proteolysis and activation of protein kinase C plays a central role in neutrophil apoptosis. Blood 94, 291-301
4. Fadok, V. A., Bratton, D. L., Konowal, A., Freed, P. W., Westcott, J. Y., and Henson, P. M. (1998) Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/ paracrine mechanisms involving TGF, PGE2, and PAF. J. Clin. Invest. 101, 890-898
5. Haringman, J. J., Gerlag, D. M., Zwinderman, A. H., Smeets, T. J., Kraan, M. C., Baeten, D., McInnes, I. B., Bresnihan, B., and Tak, P. P. (2005) Synovial tissue macrophages. A sensitive biomarker for response to treatment in patients with rheumatoid arthritis. Ann. Rheum. Dis. 64, 834-838
6. Lumeng, C. N., Bodzin, J. L., and Saltiel, A. R. (2007) Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 117, 175-184
7. Lutgens, E., Lievens, D., Beckers, L., Wijnands, E., Soehnlein, O., Zernecke, A., Seijkens, T., Engel, D., Cleutjens, J., Keller, A. M., Naik, S. H., Boon, L., Oufella, H. A., Mallat, Z., Ahonen, C. L., Noelle, R. J., de Winther, M. P., Daemen, M. J., Biessen, E. A., and Weber, C. (2010) Deficient CD40- TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile. J. Exp. Med. 207, 391-404
8. Woollard, K. J., and Geissmann, F. (2010) Monocytes in atherosclerosis. Subsets and functions. Nat. Rev. Cardiol. 7, 77-86
9. Gilroy, D. W., Lawrence, T., Perretti, M., and Rossi, A. G. (2004) Inflammatory resolution. New opportunities for drug discovery. Nat. Rev. Drug Discov. 3, 401-416
10. Serhan, C. N., Brain, S. D., Buckley, C. D., Gilroy, D. W., Haslett, C., O'Neill, L. A., Perretti, M., Rossi, A. G., and Wallace, J. L. (2007) Resolution of inflammation. State of the art, definitions and terms. FASEB J. 21, 325-332
11. Duffin, R., Leitch, A. E., Fox, S., Haslett, C., and Rossi, A. G. (2010) Targeting granulocyte apoptosis. Mechanisms, models, and therapies. Immunol. Rev. 236, 28-40
12. Edwards, J. P., Zhang, X., Frauwirth, K. A., and Mosser, D. M. (2006) Biochemical and functional characterization of three activated macrophage populations. J. Leukocyte Biol. 80, 1298-1307
13. Mosser, D. M., and Edwards, J. P. (2008) Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8, 958-969
14. Gordon, S., and Martinez, F. O. (2010) Alternative activation of macrophages. Mechanism and functions. Immunity 32, 593-604
15. Sica, A., and Mantovani, A. (2012) Macrophage plasticity and polarization. In vivo veritas. J. Clin. Invest. 122, 787-795
16. Yamamoto, M., Sato, S., Hemmi, H., Hoshino, K., Kaisho, T., Sanjo, H., Takeuchi, O., Sugiyama, M., Okabe, M., Takeda, K., and Akira, S. (2003) Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301, 640-643
17. Mosser, D. M. (2003) The many faces of macrophage activation. J. Leukocyte Biol. 73, 209-212
18. Mosser, D. M., and Handman, E. (1992) Treatment of murine macrophages with interferon-gamma inhibits their ability to bind leishmania promastigotes. J. Leukocyte Biol. 52, 369-376
19. Michlewska, S., Dransfield, I., Megson, I. L., and Rossi, A. G. (2009) Macrophage phagocytosis of apoptotic neutrophils is critically regulated by the opposing actions of pro-inflammatory and anti-inflammatory agents. Key role for TNF. FASEB J. 23, 844-854
20. Leidi, M., Gotti, E., Bologna, L., Miranda, E., Rimoldi, M., Sica, A., Roncalli, M., Palumbo, G. A., Introna, M., and Golay, J. (2009) M2 macrophages phagocytose rituximab-opsonized leukemic targets more efficiently than M1 cells in vitro. J. Immunol. 182, 4415-4422
21. Chihara, T., Hashimoto, M., Osman, A., Hiyoshi-Yoshidomi, Y., Suzu, I., Chutiwitoonchai, N., Hiyoshi, M., Okada, S., and Suzu, S. (2012) HIV-1 proteins preferentially activate anti-inflammatory M2-type macrophages. J. Immunol. 188, 3620-3627
22. Delgado, M., Munoz-Elias, E. J., Gomariz, R. P., and Ganea, D. (1999) Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NFB and IFN regulatory factor 1 activation. J. Immunol. 162, 4685-4696
23. Gerber, J. S., and Mosser, D. M. (2001) Reversing lipopolysaccharide toxicity by ligating the macrophage Fc receptors. J. Immunol. 166, 6861-6868
24. Anderson, C. F., and Mosser, D. M. (2002) A novel phenotype for an activated macrophage. The type 2 activated macrophage. J. Leukocyte Biol. 72, 101-106
25. Ando, M., Tu, W., Nishijima, K., and Iijima, S. (2008) Siglec-9 enhances IL-10 production in macrophages via tyrosine-based motifs. Biochem. Biophys. Res. Commun. 369, 878-883
26. Bastos, K. R., Alvarez, J. M., Marinho, C. R., Rizzo, L. V., and Lima, M. R. (2002) Macrophages from IL-12p40-deficient mice have a bias toward the M2 activation profile. J. Leukocyte Biol. 71, 271-278
27. Odegaard, J. I., Ricardo-Gonzalez, R. R., Goforth, M. H., Morel, C. R., Subramanian, V., Mukundan, L., Red Eagle, A., Vats, D., Brombacher, F., Ferrante, A. W., and Chawla, A. (2007) Macrophage-specific PPAR controls alternative activation and improves insulin resistance. Nature 447, 1116-1120
28. Duffield, J. S. (2003) The inflammatory macrophage. A story of Jekyll and Hyde. Clin. Sci. 104, 27-38
29. Nathan, C., Ding, A. (2010) Nonresolving inflammation. Cell 140, 871-882
30. Tseng, S. C., Espana, E. M., Kawakita, T., Di Pascuale, M. A., Li, W., He, H., Liu, T. S., Cho, T. H., Gao, Y. Y., Yeh, L. K., and Liu, C.-Y. (2004) How does amniotic membrane work? Ocul. Surf. 2, 177-187
31. Dua, H. S., Gomes, J. A., King, A. J., and Maharajan, V. S. (2004) The amniotic membrane in ophthalmology. Surv. Ophthalmol. 49, 51-77
32. Bouchard, C. S., and John, T. (2004) Amniotic membrane transplantation in the management of severe ocular surface disease. Indications and outcomes. Ocul. Surf. 2, 201-211
33. Park, W. C., and Tseng, S. C. (2000) Modulation of acute inflammation and keratocyte death by suturing, blood and amniotic membrane in PRK. Invest. Ophthalmol. Vis. Sci. 41, 2906-2914
34. Wang, M. X., Gray, T. B., Park, W. C., Prabhasawat, P., Culbertson, W., Forster, R., Hanna, K., and Tseng, S. C. (2001) Corneal haze and apoptosis is reduced by amniotic membrane matrix in excimer laser photoablation in rabbits. J. Cataract Refract. Surg. 27, 310-319
35. Shimmura, S., Shimazaki, J., Ohashi, Y., and Tsubota, K. (2001) Antiinflammatory effects of amniotic membrane transplantation in ocular surface disorders. Cornea 20, 408-413
36. Bauer, D., Wasmuth, S., Hennig, M., Baehler, H., Steuhl, K. P., and Heiligenhaus, A. (2009) Amniotic membrane transplantation induces apoptosis in T lymphocytes in murine corneas with experimental herpetic stromal keratitis. Invest. Ophthalmol. Vis. Sci. 50, 3188-3198
37. Bauer, D., Wasmuth, S., Hermans, P., Hennig, M., Meller, K., Meller, D., van Rooijen,N., Tseng, S. C., Steuhl, K. P., and Heiligenhaus, A. (2007) On the influence of neutrophils in corneas with necrotizing HSV-1 keratitis following amniotic membrane transplantation. Exp. Eye Res. 85, 335-345
38. Heiligenhaus, A., Bauer, D., Meller, D., Steuhl, K. P., and Tseng, S. C. (2001) Improvement of HSV-1 necrotizing keratitis with amniotic membrane transplantation. Invest. Ophthalmol. Vis. Sci. 42, 1969-1974
39. Bauer, D., Hennig, M., Wasmuth, S., Baehler, H., Busch, M., Steuhl, K. P., Thanos, S., and Heiligenhaus, A. (2012) Amniotic membrane induces peroxisome proliferator-activated receptor-gamma positive alternatively activated macrophages. Invest. Ophthalmol. Vis. Sci. 53, 799-810
40. Li, W., He, H., Kawakita, T., Espana, E. M., and Tseng, S. C. (2006) Amniotic membrane induces apoptosis of interferon-gamma activited macrophages in vitro. Exp. Eye Res. 82, 282-292
41. He, H., Li, W., Chen, S. Y., Zhang, S., Chen, Y. T., Hayashida, Y., Zhu, Y. T., and Tseng, S. C. (2008) Suppression of activation and induction of apoptosis in RAW264.7 cells by amniotic membrane extract. Invest. Ophthalmol. Vis. Sci. 49, 4468-4475
42. Zhang, S., He, H., Day, A. J., and Tseng, S. C. (2012) Constitutive expression of inter-inhibitor (I-I) family proteins and tumor necrosis factorstimulated gene-6 (TSG-6) by human amniotic membrane epithelial and stromal cells supporting formation of the heavy chain-hyaluronan (HCHA) complex. J. Biol. Chem. 287, 12433-12444
43. He, H., Li, W., Tseng, D. Y., Zhang, S., Chen, S. Y., Day, A. J., and Tseng, S. C. (2009) Biochemical characterization and function of complexes formed by hyaluronan and the heavy chains of inter-inhibitor (HC-HA) purified from extracts of human amniotic membrane. J. Biol. Chem. 284, 20136-20146
44. Shay, E., He, H., Sakurai, S., and Tseng, S. C. (2011) Inhibition of angiogenesis by HC-HA, a complex of hyaluronan and the heavy chain of inter-inhibitor, purified from human amniotic membrane. Invest. Ophthalmol. Vis. Sci. 52, 2669-2678
45. Rossi, A. G., Sawatzky, D. A., Walker, A., Ward, C., Sheldrake, T. A., Riley, N. A., Caldicott, A., Martinez-Losa, M., Walker, T. R., Duffin, R., Gray, M., Crescenzi, E., Martin, M. C., Brady, H. J., Savill, J. S., Dransfield, I., and Haslett, C. (2006) Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis. Nat. Med. 12, 1056-1064
46. Lasunskaia, E. B., Campos, M. N., de Andrade, M. R., Damatta, R. A., Kipnis, T. L., Einicker-Lamas, M., and Da Silva, W. D. (2006) Mycobacteria directly induce cytoskeletal rearrangements for macrophage spreading and polarization through TLR2-dependent PI3K signaling. J. Leukocyte Biol. 80, 1480-1490
47. Zhao, M., Yoneda, M., Ohashi, Y., Kurono, S., Iwata, H., Ohnuki, Y., and Kimata, K. (1995) Evidence for the covalent binding of SHAP, heavy chains of inter-trypsin inhibitor, to hyaluronan. J. Biol. Chem. 270, 26657-26663
48. Enghild, J. J., Salvesen, G., Hefta, S. A., Thøgersen, I. B., Rutherfurd, S., and Pizzo, S. V. (1991) Chondroitin 4-sulfate covalently cross-links the chains of the human blood protein pre-inhibitor. J. Biol. Chem. 266, 747-751
49. Lee, G. W., Lee, T. H., and Vilcek, J. (1993) TSG-14, a tumor necrosis factor- and IL-1-inducible protein, is a novel member of the pentaxin family of acute phase proteins. J. Immunol. 150, 1804-1812
50. Salustri, A., Garlanda, C., Hirsch, E., De Acetis,M., Maccagno, A., Bottazzi, B., Doni, A., Bastone, A., Mantovani, G., Beck Peccoz,P., Salvatori, G., Mahoney, D. J., Day, A. J., Siracusa, G., Romani, L., and Mantovani, A. (2004) PTX3 plays a key role in the organization of the cumulus oophorus extracellular matrix and in in vivo fertilization. Development 131, 1577-1586
51. Inforzato, A., Baldock, C., Jowitt, T. A., Holmes, D. F., Lindstedt, R., Marcellini, M., Rivieccio, V., Briggs, D. C., Kadler, K. E., Verdoliva, A., Bottazzi, B., Mantovani, A., Salvatori, G., and Day, A. J. (2010) The angiogenic inhibitor long pentraxin PTX3 forms an asymmetric octamer with two binding sites for FGF2. J. Biol. Chem. 285, 17681-17692
52. Benard, V., Bohl, B. P., and Bokoch, G. M. (1999) Characterization of Rac and Cdc42 activation in chemoattractant-stimulated human neutrophils using a novel assay for active GTPases. J. Biol. Chem. 274, 13198-13204
53. Lee, A., Whyte, M. K., and Haslett, C. (1993) Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators. J. Leukocyte Biol. 54, 283-288
54. Leitch, A. E., Riley, N. A., Sheldrake, T. A., Festa, M., Fox, S., Duffin, R., Haslett, C., and Rossi, A. G. (2010) The cyclin-dependent kinase inhibitor R-roscovitine down-regulates Mcl-1 to override pro-inflammatory signalling and drive neutrophil apoptosis. Eur. J. Immunol. 40, 1127-1138
55. Rhee, S. H., and Hwang, D. (2000) Murine TOLL-like receptor 4 confers lipopolysaccharide responsiveness as determined by activation of NF-B and expression of the inducible cyclooxygenase. J. Biol. Chem. 275, 34035-34040
56. Frost, G. I., and Stern, R. (1997) A microtiter-based assay for hyaluronidase activity not requiring specialized reagents. Anal. Biochem. 251, 263-269
57. Aderem, A., and Underhill, D. M. (1999) Mechanisms of phagocytosis in macrophages. Annu. Rev. Immunol. 17, 593-623
58. Underhill, D. M., and Goodridge, H. S. (2012) Information processing during phagocytosis. Nat. Rev. Immunol. 12, 492-502
59. Murray, P. J., and Wynn, T. A. (2011) Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 11, 723-737
60. Krausgruber, T., Blazek, K., Smallie, T., Alzabin, S., Lockstone, H., Sahgal, N., Hussell, T., Feldmann, M., and Udalova, I. A. (2011) IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat. Immunol. 12, 231-238
61. Barnes, B. J., Kellum, M. J., Field, A. E., and Pitha, P. M. (2002) Multiple regulatory domains of IRF-5 control activation, cellular localization, and induction of chemokines that mediate recruitment ofTlymphocytes. Mol. Cell. Biol. 22, 5721-5740
62. Lin, R., Yang, L., Arguello, M., Penafuerte, C., and Hiscott, J. (2005) A CRM1-dependent nuclear export pathway is involved in the regulation of IRF-5 subcellular localization. J. Biol. Chem. 280, 3088-3095
63. Schroder, K., Sweet, M. J., and Hume, D. A. (2006) Signal integration between IFNgamma and TLR signalling pathways in macrophages. Immunobiology 211, 511-524
64. Yingsung, W., Zhuo, L., Morgelin, M., Yoneda, M., Kida, D., Watanabe, H., Ishiguro, N., Iwata, H., and Kimata, K. (2003) Molecular heterogeneity of the SHAP-hyaluronan complex. Isolation and characterization of the complex in synovial fluid from patients with rheumatoid arthritis. J. Biol. Chem. 278, 32710-32718
65. Zhuo, L., Kanamori, A., Kannagi, R., Itano, N., Wu, J., Hamaguchi, M., Ishiguro, N., and Kimata, K. (2006) SHAP potentiates the CD44-mediated leukocyte adhesion to the hyaluronan substratum. J. Biol. Chem. 281, 20303-20314
66. Zhu, L., Zhuo, L., Kimata, K., Yamaguchi, E., Watanabe, H., Aronica, M. A., Hascall, V. C., and Baba, K. (2010) Deficiency in the serum-derived hyaluronan-associated protein-hyaluronan complex enhances airway hyperresponsiveness in a murine model of asthma. Int. Arch. Allergy Immunol. 153, 223-233
67. Scarchilli, L., Camaioni, A., Bottazzi, B., Negri, V., Doni, A., Deban, L., Bastone, A., Salvatori, G., Mantovani, A., Siracusa, G., and Salustri, A. (2007) PTX3 interacts with inter-trypsin inhibitor. Implications for hyaluronan organization and cumulus oophorus expansion. J. Biol. Chem. 282, 30161-30170
68. Otake, K., Uchida, K., Yoshiyama, S., Inoue, M., Okita, Y., Watanabe, H., Inoue, Y., Mohri, Y., Miki, C., and Kusunoki, M. (2008) Effects of a hyaluronate- carboxymethylcellulose membrane (Seprafilm) on human polymorphonuclear neutrophil functions. J. Surg. Res. 149, 243-249
69. Koh, T. J., and DiPietro, L. A. (2011) Inflammation and wound healing. The role of the macrophage. Expert. Rev. Mol. Med. 13, e23
70. Frisch, S. M., and Screaton, R. A. (2001) Anoikis mechanisms. Curr. Opin. Cell Biol. 13, 555-562
71. Lesley, J., Schulte, R., and Hyman, R. (1990) Binding of hyaluronic acid to lymphoid cell lines is inhibited by monoclonal antibodies against Pgp-1. Exp. Cell Res. 187, 224-233
72. McDonald, B., McAvoy, E. F., Lam, F., Gill, V., de la Motte, C., Savani, R. C., and Kubes, P. (2008) Interaction of CD44 and hyaluronan is the dominant mechanism for neutrophil sequestration in inflamed liver sinusoids. J. Exp. Med. 205, 915-927
73. Termeer, C., Johannsen, H., Braun, T., Renkl, A., Ahrens, T., Denfeld, R. W., Lappin, M. B., Weiss, J. M., and Simon, J. C. (2001) The role of CD44 during CD40 ligand-induced dendritic cell clustering and maturation. J. Leukocyte Biol. 70, 715-722
74. Lesley, J., Gál, I., Mahoney, D. J., Cordell, M. R., Rugg, M. S., Hyman, R., Day, A. J., and Mikecz, K. (2004) TSG-6 modulates the interaction between hyaluronan and cell surface CD44. J. Biol. Chem. 279, 25745-25754
75. Forrester, J. V., and Balazs, E. A. (1980) Inhibition of phagocytosis by high molecular weight hyaluronate. Immunology 40, 435-446
76. Suzuki, Y., and Yamaguchi, T. (1993) Effects of hyaluronic acid on macrophage phagocytosis and active oxygen release. Agents Actions 38, 32-37
77. Tamoto, K., Nochi, H., Tada, M., Shimada, S., Mori, Y., Kataoka, S., Suzuki, Y., and Nakamura, T. (1994) High-molecular-weight hyaluronic acids inhibit chemotaxis and phagocytosis but not lysosomal enzyme release induced by receptor-mediated stimulations in guinea pig phagocytes. Microbiol. Immunol. 38, 73-80
78. Ravasi, T., Wells, C., Forest, A., Underhill, D. M., Wainwright, B. J., Aderem, A., Grimmond, S., and Hume, D. A. (2002) Generation of diversity in the innate immune system. Macrophage heterogeneity arises from gene-autonomous transcriptional probability of individual inducible genes. J. Immunol. 168, 44-50
79. Cuetara, B. L., Crotti, T. N., O'Donoghue, A. J., and McHugh, K. P. (2006) Cloning and characterization of osteoclast precursors from the RAW264.7 cell line. In Vitro Cell Dev. Biol. Anim 42, 182-188
80. Strassmann, G., Patil-Koota, V., Finkelman, F., Fong, M., and Kambayashi, T. (1994) Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2. J. Exp. Med. 180, 2365-2370
81. Erwig, L. P., and Henson, P. M. (2007) Immunological consequences of apoptotic cell phagocytosis. Am. J. Pathol. 171, 2-8
82. Fleming, B. D., and Mosser, D. M. (2011) Regulatory macrophages. Setting the threshold for therapy. Eur. J. Immunol. 41, 2498-2502
83. Perdiguero, E., Kharraz, Y., Serrano, A. L., and Muñoz- Cánoves, P. (2012) MKP-1 coordinates ordered macrophage-phenotype transitions essential for stem cell-dependent tissue repair. Cell Cycle 11, 877- 886
84. Haskó, G., Pacher, P., Deitch, E. A., and Vizi, E. S. (2007) Shaping of monocyte and macrophage function by adenosine receptors. Pharmacol. Ther. 113, 264-275
85. Gordon, S., and Taylor, P. R. (2005) Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5, 953-964
86. Lucas, M., Stuart, L. M., Zhang, A., Hodivala-Dilke, K., Febbraio, M., Silverstein, R., Savill, J., and Lacy-Hulbert, A. (2006) Requirements for apoptotic cell contact in regulation of macrophage responses. J. Immunol. 177, 4047-4054
87. Stein, M., Keshav, S., Harris, N., and Gordon, S. (1992) Interleukin 4 potently enhances murine macrophage mannose receptor activity. A marker of alternative immunologic macrophage activation. J. Exp. Med. 176, 287-292
88. Paun, A., Reinert, J. T., Jiang, Z., Medin, C., Balkhi, M. Y., Fitzgerald, K. A., and Pitha, P. M. (2008) Functional characterization of murine interferon regulatory factor 5 (IRF-5) and its role in the innate antiviral response. J. Biol. Chem. 283, 14295-14308
89. Krausgruber, T., Saliba, D., Ryzhakov, G., Lanfrancotti, A., Blazek, K., and Udalova, I. A. (2010) IRF5 is required for late-phase TNF secretion by human dendritic cells. Blood 115, 4421-4430
90. Paun, A., Bankoti, R., Joshi, T., Pitha, P. M., and Stäger, S. (2011) Critical role of IRF-5 in the development of T helper 1 responses to Leishmania donovani infection. PLoS Pathog. 7, e1001246